Luca Bertero
University of Turin
CancerInternal medicineRadiologySurgeryPathologyMagnetic resonance imagingOncologyImmunohistochemistryPathologicalBiopsyChemotherapyTemozolomideBevacizumabBrain metastasisGliomaChemotherapy regimenTumor progressionNeuro oncologyCancer researchRadiation therapyCentral nervous systemMedicineBiology
Publications 116
#1Daniele PerloH-Index: 2
#2Enzo TartaglioneH-Index: 5
Last. Marco GrangettoH-Index: 23
view all 0 authors...
#1Lucía ZhuH-Index: 4
Last. Manuel ValienteH-Index: 33
view all 10 authors...
#1Mario Preti (UNITO: University of Turin)H-Index: 20
#2Fulvio Borella (UNITO: University of Turin)H-Index: 7
Last. Leonardo Micheletti (UNITO: University of Turin)H-Index: 16
view all 11 authors...
Superficially, invasive vulvar squamous cell carcinoma (SISCCA) (FIGO stage IA) is a rare subset of vulvar cancer defined as a single lesion measuring ≤2 cm with a depth of invasion of ≤1.0 mm. This is a retrospective study performed on 48 patients with SISCCA, surgically treated between 1981 and 2018 at the S. Anna Hospital, University of Turin, to evaluate pathological characteristics and prognosis of these tumors. Ten patients (21%) recurred: seven (14%) as SISCCA and three (7%) as deeply inv...
Rare central nervous system (CNS) tumours represent a unique challenge. Given the difficulty of conducting dedicated clinical trials, there is a lack of therapies for these tumours supported by high quality evidence, and knowledge regarding the impact of standard treatments (i.e., surgery, radiotherapy or chemotherapy) is commonly based on retrospective studies. Recently, new molecular techniques have led to the discovery of actionable molecular alterations. The aim of this article is to review ...
#1Anna Maria Buccoliero (UniFI: University of Florence)H-Index: 23
#2Chiara Caporalini (UniFI: University of Florence)H-Index: 5
Last. Carmen Barba (UniFI: University of Florence)H-Index: 26
view all 22 authors...
#1Luca Bertero (UNITO: University of Turin)H-Index: 14
#2Luisella Righi (UNITO: University of Turin)H-Index: 33
Last. Andreas von Deimling (DKFZ: German Cancer Research Center)H-Index: 130
view all 16 authors...
Abstract Diagnosis of malignant pleural mesothelioma (MPM) is a challenging task because of its potential overlap with other neoplasms or even with reactive conditions. Recently, DNA methylation analysis proved to be an effective tool for tumor diagnosis. In the present study, this approach was tested for MPM diagnosis. A discovery (n=33) and an independent validation cohort (n=46) of MPM samples were subjected to array-based DNA methylation analyses and their DNA methylation patterns were compa...
#1Luca Bertero (UNITO: University of Turin)H-Index: 14
#2Alessandro Gambella (UNITO: University of Turin)H-Index: 4
Last. Paola Cassoni (UNITO: University of Turin)H-Index: 56
view all 9 authors...
Aims null Novel prognostic markers are warranted for gastrointestinal stromal tumours. Caveolin-1 is a multifunctional protein that proved to be associated with outcome in multiple tumour types. Aim of this study was to investigate Caveolin-1 expression and prognostic efficacy in a series of gastrointestinal stromal tumours. null Methods null Caveolin-1 expression was assessed by immunohistochemistry in a retrospective series of 66 gastrointestinal stromal tumours representative of the different...
#4Andrea Bianconi (UNITO: University of Turin)H-Index: 1
#1Luca Bertero (UNITO: University of Turin)H-Index: 14
#2Fulvio Borella (UNITO: University of Turin)H-Index: 7
Last. Chiara Benedetto (UNITO: University of Turin)H-Index: 57
view all 12 authors...
Infection by SARS-CoV-2 has been shown to involve a wide range of organs and tissues, leading to a kaleidoscope of clinical conditions. Within this spectrum, an involvement of the fetal-maternal unit could be expected, but, so far, the histopathological evaluation of placentas delivered by women with SARS-CoV-2 infection did not show distinct hallmarks. A consecutive series of 11 placentas, delivered by 10 women with COVID-19 admitted to our Obstetrics and Gynecology clinic have been investigate...
1 CitationsSource
#1Luca Tonella (UNITO: University of Turin)H-Index: 3
#2Valentina Pala (UNITO: University of Turin)H-Index: 2
Last. Pietro Quaglino (UNITO: University of Turin)H-Index: 52
view all 16 authors...
Melanoma is one of the most aggressive skin cancers. The 5-year survival rate of stage III melanoma patients ranges from 93% (IIIA) to 32% (IIID) with a high risk of recurrence after complete surgery. The introduction of target and immune therapies has dramatically improved the overall survival, but the identification of patients with a high risk of relapse who will benefit from adjuvant therapy and the determination of the best treatment choice remain crucial. Currently, patient prognosis is ba...